CAS 828934-41-4

Acido 2-ossiranecarbossilico, 2-[6-(4-clorofenossi)esil]-, sale di sodio (1:1), (2R)-

Descrizione:

Acido 2-ossiranecarbossilico, 2-[6-(4-clorofenossi)esil]-, sale di sodio (1:1), (2R)- è un composto chimico caratterizzato dalla sua struttura unica che include un gruppo epossido (ossirano) e un gruppo funzionale acido carbossilico. La presenza del sale di sodio indica che il composto è probabilmente solubile in acqua, il che può aumentare la sua utilità in varie applicazioni, come nei farmaci o negli agrochimici. Il gruppo 4-clorofenossile contribuisce alle sue caratteristiche idrofobiche, influenzando potenzialmente la sua attività biologica e interazione con altre molecole. La stereochimica del composto, indicata dalla designazione (2R), suggerisce disposizioni spaziali specifiche che possono influenzare la sua reattività e interazioni nei sistemi biologici. In generale, questo composto può presentare proprietà interessanti grazie alla sua combinazione di gruppi funzionali, rendendolo un argomento di interesse per ulteriori ricerche in campi come la chimica medicinale o la scienza dei materiali.

Formula: C₁₅H₁₉ClO₄·Na

InChI: InChI=1S/C15H19ClO4.Na/c16-12-5-7-13(8-6-12)19-10-4-2-1-3-9-15(11-20-15)14(17)18;/h5-8H,1-4,9-11H2,(H,17,18);/t15-;/m1./s1

InChI key: InChIKey=ZUMIFLJZQDMWAU-XFULWGLBSA-N

SMILES: C(CCCCCOC1=CC=C(Cl)C=C1)[C@]2(C(O)=O)CO2.[Na]

Sinonimi:

• (+)-Etomoxir Sodium Hydrate
• (+)-Etomoxir hydrate sodium salt
• 2-Oxiranecarboxylic acid, 2-[6-(4-chlorophenoxy)hexyl]-, sodium salt (1:1), (2R)-
• Anti-eapii (ttrap)
• Oxiranecarboxylic acid, 2-[6-(4-chlorophenoxy)hexyl]-, sodium salt, (2R)-
• R(+)-2-[6-(4-Chlorophenoxy)Hexyl]-Oxirane-2-Carboxylic Acid Sodium Salt Hydrate
• R(+)-2-[6-(4-Chlorophenoxy)hexyl]-oxirane-2-carboxylic
• sodium (2R)-2-[6-(4-chlorophenoxy)hexyl]oxirane-2-carboxylate hydrate

Etomoxir sodium salt

CAS: 828934-41-4

Etomoxir sodium salt

Purezza: ≥98%

Peso molecolare: 320.74g/mol

Ref: 54-BUP10353

(R)-(+)-Etomoxir sodium

CAS: 828934-41-4

(R)-(+)-Etomoxir sodium

Purezza: 98%

Peso molecolare: 320.74g/mol

Ref: 54-BISN0105

Etomoxir Impurity 1 Sodium Salt

CAS: 828934-41-4

Formula: C₁₅H₁₈ClO₄·Na

Peso molecolare: 297.76 22.99

Ref: 4Z-E-232004

(+)-Etomoxir sodium salt hydrate

CAS: 828934-41-4

Formula: C₁₅H₁₈ClO₄·Na·H₂O

Purezza: (HPLC) ≥ 98.0%

Colore e forma: White powder

Peso molecolare: 338.76

Ref: 7W-GL0593

Etomoxir Impurity 1-13C6 Sodium Salt

CAS: 828934-41-4

Formula: C₉₁₃C₆H₁₈ClO₄·Na

Peso molecolare: 303.71

Ref: 4Z-E-232005

Etomoxir sodium salt

CAS: 828934-41-4

Etomoxir sodium salt ((R)-Etomoxir sodium salt) is a carnitine palmitoyltransferase 1a (CPT-1a) inhibitor that blocks fatty acid synthesis.

Formula: C₁₅H₁₈ClO₄·Na

Purezza: 99.34% - 99.82%

Colore e forma: Solid

Peso molecolare: 320.74

Ref: TM-T4535

Sodium (R)-2-(6-(4-chlorophenoxy)hexyl)oxirane-2-carboxylate

CAS: 828934-41-4

Formula: C₁₅H₁₈ClNaO₄

Purezza: 98%

Colore e forma: Liquid, No data available.

Peso molecolare: 320.74

Ref: 10-F516300

(2R)-2-[6-(4-Chlorophenoxy)hexyl]-oxiranecarboxylic Acid Sodium Salt

Prodotto controllato

CAS: 828934-41-4

Applications (2R)-2-[6-(4-Chlorophenoxy)hexyl]-oxiranecarboxylic Acid Sodium Salt is a carnitine palmatoyltransferase 1 inhibitor. It is also a chemo-sensitizing agent that is able to induce apoptosis in HL60 cells when used with glycolytic inhibitors such as 2-deoxy-D-glucose (D239000) and lonidamine (L469458).
Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package
References Estan, M. C., et al.: PLoS One. 9, e115250 (2014); Li, A. J., et al.: Am J Physiol Regul Integr Comp Physiol. 310, R724 (2016)

Formula: C₁₅H₁₈ClO₄·Na

Colore e forma: White To Off-White

Peso molecolare: 320.744

Ref: TR-C433080

(2R)-2-[6-(4-Chlorophenoxy)hexyl]-2-oxiranecarboxylic acid sodium

CAS: 828934-41-4

(+)-Etomoxir sodium salt hydrate is a chemical compound classified as a carnitine palmitoyltransferase 1 (CPT1) inhibitor, which is a compound derived synthetically. Its mode of action involves the inhibition of the enzyme CPT1, which is pivotal in the transport of long-chain fatty acids into the mitochondria for β-oxidation. This inhibition effectively blocks fatty acid oxidation pathways, leading to alterations in metabolic states.Etomoxir is commonly utilized in scientific research to study metabolic processes, particularly those related to energy metabolism and metabolic disorders. It serves as a valuable tool in exploring mechanisms involved in diabetes, obesity, and cardiovascular diseases by allowing researchers to scrutinize the metabolic adaptations to impaired fatty acid oxidation. Furthermore, it is used in cellular and animal models to investigate metabolic inflexibility and mitochondrial function. Its application extends to cancer research, where metabolic reprogramming is a focus, aiding in the understanding of tumor progression and potential therapeutic interventions targeting metabolic pathways.

Formula: C₁₅H₁₈ClNaO₄

Peso molecolare: 320.74 g/mol

Ref: 3D-BE164435